Cargando…
Acteoside protects retinal ganglion cells from experimental glaucoma by activating the PI3K/AKT signaling pathway via caveolin 1 upregulation
BACKGROUND: Glaucoma is the second leading cause of blindness in the world and is characterized by optic neuropathy and degeneration of retinal ganglion cells (RGCs). Our preliminary research found that acteoside can inhibit autophagy-induced apoptosis of RGCs via the phosphatidylinositol 3-kinase (...
Autores principales: | Xi, Xiaoting, Chen, Qianbo, Ma, Jia, Wang, Xuewei, Xia, Yuan, Wen, Xuewei, Cai, Bin, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011318/ https://www.ncbi.nlm.nih.gov/pubmed/35433984 http://dx.doi.org/10.21037/atm-22-136 |
Ejemplares similares
-
Acteoside inhibits autophagic apoptosis of retinal ganglion cells to rescue glaucoma‐induced optic atrophy
por: Chen, Qianbo, et al.
Publicado: (2019) -
Acteoside attenuates hydrogen peroxide-induced injury of retinal ganglion cells via the CASC2/miR-155/mTOR axis
por: Xi, Xiaoting, et al.
Publicado: (2022) -
Recombinant human klotho protects against hydrogen peroxide-mediated injury in human retinal pigment epithelial cells via the PI3K/Akt-Nrf2/HO-1 signaling pathway
por: Wen, Xuewei, et al.
Publicado: (2022) -
Overexpression of Optic Atrophy Type 1 Protects Retinal Ganglion Cells and Upregulates Parkin Expression in Experimental Glaucoma
por: Hu, Xinxin, et al.
Publicado: (2018) -
Overexpression of parkin protects retinal ganglion cells in experimental glaucoma
por: Dai, Yi, et al.
Publicado: (2018)